Search

everythinglearnresearchcommunity

for

Search:↓

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Hair follicles in people with alopecia have lower levels of a key blood vessel growth protein.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Macrophage-stimulating protein helps hair grow and can start hair growth phase in mice and human hair samples.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

ROR2 is essential for hair follicle stem cell renewal and maintenance.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

New mutations in the SLC39A4 gene found in twins help understand the genetic cause of acrodermatitis enteropathica.

Certain immune cells in the skin can stop hair from growing.

Susan Lee Lindquist was a pioneering biologist who made significant contributions to understanding protein folding and its role in disease.

Removing Sprouty genes in mice causes various hormone-related issues but does not increase cancer risk by one year of age.

EGFR inhibitors can cause unusual localized hair growth.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

The African spiny mouse heals skin without scarring due to different protein activity compared to the common house mouse, which heals with scarring.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Bone Morphogenetic Proteins (BMPs) help control skin health, hair growth, and color, and could potentially be used to treat skin and hair disorders.

Blocking JAK-STAT signaling can lead to hair growth.

Type I interferons play a key role in the development of various skin diseases.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.